It is also a relatively expensive procedure, and one which requires the intravenous injection of gadolinium, which has been implicated in a rare reaction called nephrogenic systemic fibrosis.
22.
Commonly used MRI contrast agents have a good safety profile but linear non-ionic agents in particular have been implicated in nephrogenic systemic fibrosis in patients with severely impaired renal function.
23.
In addition to its role in genetically determined nephrogenic diabetes insipidus, aquaporins also play a key role in acquired forms of nephrogenic diabetes insipidus ( disorders that cause increased urine production ).
24.
In addition to its role in genetically determined nephrogenic diabetes insipidus, aquaporins also play a key role in acquired forms of nephrogenic diabetes insipidus ( disorders that cause increased urine production ).
25.
Nephrogenic diabetes insipidus is caused by an improper response of the kidney to ADH, leading to a decrease in the ability of the kidney to concentrate the urine by removing free water.
26.
If there is no change in the water loss despite fluid deprivation, desmopressin may be administered to distinguish between the two types of diabetes insipidus which are central & nephrogenic diabetes insipidus.
27.
Photopheresis is also used as an experimental treatment in patients with cardiac, pulmonary and renal allograft rejection, graft-versus-host disease, autoimmune diseases, nephrogenic systemic fibrosis and ulcerative colitis.
28.
Patients with severe renal dysfunction, as the Gadolinium contrast agent poses a very small risk of causing Nephrogenic Systemic Fibrosis ( NSF ) and is therefore contraindicated when the eGFR is less than 30.
29.
Re-activation of PAX8 ( or Pax2 ) expression has been reported in pediatric Wilms Tumors, almost all subtypes of renal cell carcinoma, nephrogenic adenomas, ovarian cancer cells, bladder, prostate, and endometrial carcinomas.
30.
On his return from England he joined the prestigious team at the Institute of Physiology, with Luis Federico Leloir, Juan Fasciolo, Juan Mu�oz, and Alberto Taquini to work for a few years on the mechanism of nephrogenic hypertension.
